Trial intelligence / Profile preview

Progesterone supplementation in low-progesterone HRT frozen embryo transfer cycles

ACTRN12617001016325Phase 4Withdrawn

Sponsor
Monash IVF Group
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in infertility comparing Additional progesterone pessary with Placebo pessary (2 arms). Primary endpoint: Live birth rate. Planned start Jan 2019; status: withdrawn.

02

Drugs

progesterone
03

Conditions

infertility

Beyond the preview

Go deeper on ACTRN12617001016325.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12617001016325.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call